The four types of dementia most people don’t know exist 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims 
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies 
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1 
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide 
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval 
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship 
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand 
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review 
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales 
Why the future of marijuana legalization remains hazy despite high public support 
Is dark chocolate healthier than milk chocolate? 2 dietitians explain 
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles 
This report analyzes the worldwide markets for HIV/AIDS Testing in Thousands (volume) and US$ Thousand (value) by the following Product Segments: HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.
Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 42 companies including many key and niche players such as
- Abbott Laboratories, Inc. (US)
- Abbott Molecular, Inc. (US)
- Adaltis S.r.l. (Italy)
- Alere (US)
- Beckman Coulter, Inc. (US)
- bioMérieux SA (France)
- Bio-Rad Laboratories, Inc. (US)
- Calypte Biomedical Corporation (US)
- Chembio Diagnostic Systems, Inc. (US)
- Hologic, Inc. (US)
- Fujirebio Europe N.V. (Belgium)
- MedMira Inc. (Canada)
- OraSure Technologies, Inc. (US)
- Ortho-Clinical Diagnostics, Inc. (US)
- Quest Diagnostics, Inc. (US)
- Roche Diagnostics (Switzerland)
- Siemens Healthcare Diagnostics, Inc. (US)
- Trinity Biotech Plc. (Ireland)
Key Topics Covered:
1. INDUSTRY OVERVIEW
2. GROWTH DRIVERS AND MARKET TRENDS
3. HIV/AIDS STATISTICS
4. HIV/AIDS: UNDERSTANDING THE DISEASE
5. DIAGNOSIS OF HIV/AIDS
6. PRODUCT APPROVALS & LAUNCHES
7. RECENT INDUSTRY ACTIVITY
8. FOCUS ON SELECT GLOBAL PLAYERS
9. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 42 (including Divisions/Subsidiaries - 47)
- The United States (33)
- Canada (2)
- Europe (8)
- - France (2)
- - Italy (2)
- - Rest of Europe (4)
- Asia-Pacific (Excluding Japan) (4)
For more information visit http://www.researchandmarkets.com/research/cq3kt5/hivaids_testing
CONTACT: Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Infectious Disease Testing
